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Edited by Veli-Pekka LehtoAbstract Recently, we have cloned several Kazal-type serine
protease inhibitors from the midgut of the Triatoma infestans
bug. A single gene composed of multi Kazal-type domains, in
tandem, encodes these inhibitors. In this work, we describe the
puriﬁcation and characterization of recombinant infestins 3-4
and 4, which are potent factor XIIa inhibitors (Ki = 67 pM and
128 pM, respectively). We also identiﬁed the ﬁrst native factor
XIIa inhibitor from a hematophagous insect. The factor XIIa
inhibitory activity of infestin 4 demonstrates extremely eﬃcient
anticoagulant activity, prolonging activated partial thrombo-
plastin time by approximately 3 times. Our results suggest that
infestins perform a very important role in the T. infestans midgut
during meal acquisition and digestion by controlling blood
coagulation by means of inhibiting thrombin and factor XIIa.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The hemostatic system of vertebrate animals has two main
mechanisms to control blood loss. Initially, activated platelets
adhere and aggregate at the injury site, forming a platelet plug
that reduces or blocks blood loss. In parallel, the blood co-
agulation cascade is activated by limited proteolysis of several
factors that circulate in an inactive form in the blood. Factor
XII and plasma kallikrein activation are involved in the in-
trinsic pathway and factor VII activation and tissue factor
association in the extrinsic pathway. Both pathways converge
to form a common pathway resulting in factor Xa generation,
which activates prothrombin to thrombin. Finally, thrombin
converts ﬁbrinogen to ﬁbrin net that is stabilized by factor
XIIIa action [1].
Hematophagous animals have a vital need to interfere with
their hosts’ hemostatic system in order to obtain a blood meal.
The ﬁrst reports of substances from hematophagous animals
able to block or delay vertebrate blood coagulation date from* Corresponding author. Fax: +55-11-55723006.
E-mail address: tanaka.bioq@epm.br (A.S. Tanaka).
Abbreviations: APTT, activated partial thromboplastin time; BMMY,
buﬀered methanol-complex medium; BMM, buﬀered minimal meth-
anol; TFA, triﬂuoroacetic acid
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doi:10.1016/j.febslet.2004.10.052the XIX century [2]. Since then, many other substances from
these animals have been described, among them are molecules
with potent anti-clotting, anti-platelet aggregation, vasodila-
tors and ﬁbrinolytic activity [3–7].
Triatoma infestans (Hemiptera: Reduviidae), a vector for the
protozoan parasite Trypanosoma cruzi, which is responsible for
Chagas’ disease, is an anthropophilic and exclusively hema-
tophagous insect. This insect obtains a blood meal by injecting
its maxilla into the vertebrate’s skin [8]. Three potent thrombin
inhibitors of the Kazal-type family have been previously de-
scribed in kissing bugs (Triatominae) [9–11]. They are proba-
bly all localized in the midgut and are responsible for
inhibiting clot formation in the digestive tract of these insects
[10,11]. These thrombin inhibitors are composed of two non-
classical Kazal-type domains in tandem but, surprisingly, their
genes contain up to six Kazal-type domains that are tran-
scribed in the same mRNA molecule. The inhibitors are then
released by an unknown post transcriptional, proteolytic
mechanism.
In a previous study [11], we described a recombinant infes-
tin, encoded by a cDNA fragment containing four non-clas-
sical Kazal-type domains, obtained from the T. infestans
midgut. Infestin 1-2 was able to inhibit blood coagulation by
inhibiting thrombin activity and the four domain protein,
named infestin 1-4, besides thrombin, also inhibits factor XIIa
and factor Xa [11]. The factor Xa and XIIa inhibitory activities
were probably localized in the infestin domains 3 and 4 that
are not present in the native thrombin inhibitor (infestin 1-2).
Thrombin and factor Xa have been found to be the main
targets of hematophagous animals. Factor XIIa, a serine
protease of the contact phase of blood coagulation, is involved
in the inﬂammation process [12] and is also an important ac-
tivator of plasmin which is responsible for thrombus dissolu-
tion [1]. Few inhibitors that interfere in the intrinsic or
extrinsic blood coagulation pathway have been described [7].
The number of factor XIIa inhibitors already described is
small when compared to thrombin and factor Xa inhibitors.
Among them, ecotin is from Escherichia coli [13], few are non-
plasmatic inhibitors, and most have been isolated from plants
[14–17]. Until now, no factor XIIa inhibitor from hematoph-
agous animals was described.
In the present work, we describe the cloning and expression
of the two ﬁrst factor XIIa inhibitors (infestin 3-4 and infestin
4) belonging to the Kazal-type serine protease inhibitor family,
and infestin 3-4 is the ﬁrst factor XIIa inhibitor isolated from
hematophagous insect.ation of European Biochemical Societies.
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2.1. Protein sequence analysis
Sequence similarity searches were performed using the Blast pro-
gram [18]. Alignment of protein sequences was performed with the
ClustalW program, version 1.7 [19].
2.2. Cloning, expression and puriﬁcation of recombinant infestin 3-4
The infestin 3-4 gene was ampliﬁed from the vector pIC 2.1.2 [11] by
PCR using the primers INF3DFWD (50-ATCTCTAGAT AAA-
AGAATAC TGAAATCATG CATATGTACA AAA-30) and IN-
F4DREV (50-CCCAAGCTTT CAAAACTGTT CAACATTGCT
GCGCTGACAA CGTCC-30). The PCR product was digested with
XbaI and HindIII restriction enzymes, puriﬁed and ligated into the
pVT102a plasmid. Positive constructs were obtained after DNA
sequencing experiments. The plasmid (pIC 5.1.1) was used to transform
the Sacchramocyes cerevisiae S-78 strain [20] and standard yeast culti-
vation was carried out as previously described [11]. After yeast culti-
vation, cells were separated by centrifugation (6000 g, 20 min, 4 C)
and the supernatant was applied to a 5 ml HiTrap SP column (Amer-
sham Biosciences). The bound proteins were eluted with 50 mM sodium
acetate buﬀer, pH 5.0, containing 0–0.7 M NaCl. Fractions containing
protease inhibitory activity were pooled, concentrated and applied to a
Superose 12 column (Amersham Biosciences) pre-equilibrated with 50
mM Tris–HCl buﬀer, pH 8.0, containing 0.3 M NaCl. Fractions con-
taining protease inhibitory activity were pooled and stored at )20 C.
2.3. Cloning, expression and puriﬁcation of recombinant infestin 4
The infestin 4 gene was ampliﬁed by PCR using pIC 5.1.1 as tem-
plate and INF4DREV and INF4DFWD (50-ATCTCTAGAT AAA-
AGAGAGG TCAGAAACCC TTGCGCC-30) as primers. The PCR
product was digested with XhoI and NotI restriction enzymes and li-
gated into the plasmid pPIC9 (Invitrogen). The resulting plasmid (pIC
11.1.1) was linearized with SalI restriction enzyme to transform com-
petent Pichia pastoris GS115 yeast strain prepared according to the
manufacturer’s instructions. Yeast was incubated for 5 days in buﬀered
methanol-complex medium (BMMY) medium. After fermentation,
yeast cells were harvested by centrifugation (4000 g, 20 min, 4 C).
The recombinant infestin was puriﬁed by aﬃnity chromatography on a
trypsin-Sepharose column [11].
2.4. Kinetics assay and determination of equilibrium dissociation
constants (Ki)
The equilibrium dissociation constants for complexes of puriﬁed
infestins with bovine thrombin (E.C. 3.4.21.5), bovine trypsin (E.C.
3.4.21.4), human factor Xa (E.C. 3.4.21.6), human factor XIIa (E.C.
3.4.21.38) and human plasmin (E.C. 3.4.21.7) were determined ac-
cording to Bieth [21] using the chromogenic substrates (Chromogenix):
S2238 (HD–Phe–Pip–Arg–pNa) for thrombin, S2222 (Bz-Ile-Gly-Arg-
pNa) for trypsin and factor Xa, S2302 (HD–Pro–Phe–Arg–pNa) for
factor XIIa and S2251 (HD–Val–Leu–Lys–pNa) for plasmin. Appar-
ent Ki values were calculated by ﬁtting the steady-state velocities to the
equation describing the tight-binding inhibitor model using non-linear
regression analysis [22].
2.5. Triatoma infestans anterior midgut homogenate and native infestin
puriﬁcation
Bugs were provided by Dr. Ionizete G. Silva from Instituto de
Patologia Tropical e Saude Publica – UFG, Goiania, Brazil. Fed bugs
were maintained at 25 C until their anterior midguts had completed
digestion of the blood meal. Insects were dissected and their stomachs
stored at )20 C until homogenization. 140 stomachs were homoge-
nized in 10 mM sodium acetate buﬀer, pH 5.5, containing 50 mM
NaCl (6 ml). The homogenate was centrifuged at 16 000 g for 10 min
and the supernatant was ﬁltered through a 0.22 lm ﬁlter. Supernatant
was applied to a 1 ml Resource S column (Amersham Biosciences)
previously equilibrated with 50 mM sodium acetate buﬀer, pH 5.5, and
the bound proteins were eluted with a 0–0.7 M NaCl linear gradient.
Fractions containing factor XIIa inhibitory activity were pooled. This
material was used in NH2-terminal sequence and kinetic analysis.
2.6. NH2-terminal sequence
Puriﬁed native infestin was applied to a C8 Sephasil Peptide column
(Amersham Biosciences) and the proteins were eluted with a 0–90%acetonitrile linear gradient in 0.1% triﬂuoroacetic acid (TFA). Protein
peaks were assayed for factor XIIa inhibition and the active protein
peak was blotted on a PVDF membrane and sequenced by Edman
degradation using a PPSQ automatic sequencer (Shimatzu).
2.7. APTT-assay
50 ll r-Infestin 4 (1 lg) was pre-incubated with 50 ll of factor V,
VII, X or XII deﬁcient plasma (Diagnostica Stago, Asnieres-Sur-Seine,
France), 50 ll of a normal human plasma pool and 50 ll of activated
cephaloplastin reagent (Dade International Inc., Miami, USA) for 3
min at 37 C. Pre-warmed 25 mM calcium chloride solution (50 ll) was
then added and the clotting time recorded. This experiment was per-
formed in triplicate.3. Results
3.1. Cloning, expression and puriﬁcation of r-infestin 3-4
Using a plasmid containing the DNA fragment that encodes
infestin 1-4, the infestin 3-4 fragment was ampliﬁed and sub-
cloned into a S. cerevisiae expression vector (pVT102a). S-78
yeast cells expressed approximately 1.5 mg/l of active infestin
3-4. Due to the large volume, supernatant was lyophilized and
dialyzed to reduce salt, medium pigment and low molecular
mass contaminants. Concentrated supernatant showed inhib-
itory activities to trypsin, plasmin, factor Xa and XIIa (Fig. 1).
Puriﬁed material was used in enzymatic assays for dissociation
constant determination.
3.2. Cloning, expression and puriﬁcation of r-infestin 4
Using infestin 3-4 as template, the infestin 4 DNA fragment
was ampliﬁed and subcloned into the pPIC 9 yeast expression
vector (Pichia pastoris). Infestin 4 presented low expression
using buﬀered minimal methanol (BMM) but using BMMY the
expression level was 4 mg/l of active infestin 4. As shown in
Fig. 1, r-infestin 4 also inhibited trypsin, plasmin, factor Xa and
factor XIIa, similar to the r-infestin 3-4 activity. r-Infestin 4 was
puriﬁed by aﬃnity chromatography on trypsin-Sepharose and
appears as a 6 kDa single band in SDS–PAGE (data not shown).
3.3. Kinectic analysis of r-infestin 3-4 and 4
Dissociation constants (Ki) for both inhibitors were deter-
mined (Table 1) using Morrison non-linear regression to the
following serine proteases: trypsin, factor XIIa, plasmin, factor
Xa and thrombin. Infestin 3-4 and 4 strongly inhibited factor
XIIa (Ki ¼ 67 and 128 pM, respectively) and also trypsin,
plasmin and factor Xa (Ki in nanomolar range). The kinetic
results suggested that the third domain of infestin did not
contribute signiﬁcantly to factor XIIa inhibition.
3.4. APTT-assay
r-Infestin 4 prolonged the coagulation time of factor XIIa in
an activated partial thromboplastin time (APTT) assay by
almost three times (Fig. 2), but it did not aﬀect the APTT of
factors V, VII and X, conﬁrming that infestin 4 inhibits factor
XIIa activity.
3.5. Anterior midgut homogenate and native infestin puriﬁcation
Anterior midgut homogenate was used to isolate the native
form of factor XIIa inhibitor. The factor XIIa inhibitor was
partially puriﬁed from the midgut in an anion-exchange col-
umn (Fig. 3). Active fractions against factor XIIa were pooled,
the apparent dissociation constant (Ki) to factor XIIa was
determined and then the active material was applied to a
Fig. 1. Diagram of the infestin cDNA fragment. The gray, white, dashed and black boxes represent the domains 1, 2, 3 and 4, respectively. Lines
indicate the target proteases of the infestin domain combination.
Table 1
Dissociation constants (Ki) of recombinant infestins for diﬀerent serine proteases
Ki (nMS.E.)
1–4a 1–2a 3–4 4 NFI
Trypsin 5.2 3.2 3.1 0.7 3.3 2.6 11.0 8.6 nd
Factor XIIa 0.078 0.009 ni 0.067 0.039 0.128 0.016 0.088 0.019
Plasmin 1.1 0,2 ni 0.4 0.1 2.1 0.8 nd
Factor Xa 69.2 4.8 ni 18.2 3.8 53.0 22.2 nd
Thrombin 0.800 0.054 0.025 0.007 ni ni ni
NFI, native factor XIIa inhibitor; ni, not inhibited and nd, not determined.
a data from Campos et al. [11] .
Fig. 3. Ion-exchange chromatography of native infestin with factor
XIIa inhibitor activity. Midgut extract was applied to a Resource S
column previously equilibrated with 50 mM sodium acetate buﬀer, pH
5.0. Proteins were eluted with a linear gradient of 0–0.7 M NaCl
(dashed line). The horizontal line represents the fractions containing
factor XIIa inhibitory activity.
Fig. 2. Eﬀect of r-infestin 4 on blood coagulation factors V, VIII, X
and XII. Clotting time obtained by incubation of infestin 4 with factors
V, VII, X and XII deﬁcient plasmas. Normal human clotting time-
APTT is 24 seconds for factor V, VII and X and 88 seconds for factor
XII deﬁcient plasmas. Bars indicate standard error.
Fig. 4. Reverse-phase chromatography of native factor XIIa inhibitor.
Active factor XIIa inhibitor eluted from the Resource S column was
applied to a Sephasil peptide C8 column previously equilibrated with
0.1% TFA in water. Proteins were eluted with a 0–90% acetonitrile
linear gradient (dashed line). The horizontal line represents the frac-
tions containing factor XIIa inhibitory activity. The arrow indicates
the ﬁve ﬁrst N-terminal amino acid residues determined by automatic
amino acid sequencing.
514 I.T.N. Campos et al. / FEBS Letters 577 (2004) 512–516reverse-phase column. The factor XIIa inhibitor was active
after reverse-phase chromatography and it was possible to
determine the protein peak corresponding to the native factor
XIIa inhibitor (Fig. 4). Due to the low inhibitor concentration,
only the N-terminal sequence of the native protein was de-
termined. The amino acid sequence Gln–His–Gln–Ile–Leu
corresponds to the loop region between infestin domains 2 and
3, indicating that the native form of the inhibitor is probably
composed of two Kazal-type domains, infestin 3-4, and not
only one domain, infestin 4 (Fig. 5).4. Discussion
It is interesting to remember that hematophagous insects
have not one, but several ways to interfere with the hemo-
I.T.N. Campos et al. / FEBS Letters 577 (2004) 512–516 515static system of their hosts [23,24]. During feeding, an adult
bug is able to ingest 1–2 times his own weight in blood in
approximately 10 min [25]. This blood is then stored and
processed in the midgut [26]. A potent thrombin inhibitor
(Infestin 1-2) from the midgut of T. infestans has been pre-
viously described [11] and it was believed that infestin 1-2 was
responsible for inhibiting the ﬁnal blood cascade pathway
due to its high aﬃnity to thrombin (Ki of 43 pM). This
inhibitor might participate in the digestion and emptying
processes of the gut that can take up to several weeks.
Infestin 1-2 is composed of two Kazal type domains, similar
to other thrombin inhibitors from kissing bugs [9,10]. Infestin
1-2 is encoded by the ﬁrst two domains of a DNA fragment
that codes for a four Kazal-type domain protein. All four
domains were expressed as infestin 1-4 and inhibited not only
trypsin and thrombin, like infestin 1-2, but also plasmin,
factor Xa and factor XIIa.
At that time, our hypothesis was that domains 3 and 4
were responsible for the new inhibitory activities. So the
unknown infestins (3-4, 3 and 4) were cloned, expressed and
characterized. The expressed r-infestin 3-4 presented the
expected inhibitory activities of r-infestin 1-4 but not of
r-infestin 1-2. Firstly, r-infestin 3-4 was puriﬁed on a trypsin-Fig. 5. Alignment of the amino acid sequence of infestins 1-2 and 3-4 with o
Infestin 3-4; Inf 4, Infestin 4 (NCB Accession # AAK57342); Rhod, Rhodn
logastin 5-6 (NCB Accession # CAA10384); Bedl, Bdellin native (Swiss-Pr
P80424); and **, Reactive site. Reactive sites were determined by similarity
native factor XIIa inhibitor N-terminal sequence determined.Sepharose column, however, the eluted inhibitor was pro-
cessed in the column (data not shown) and even though it
still presented some inhibitory activity, this method was dis-
carded. Secondly, r-infestin 3-4 was puriﬁed using classical
puriﬁcation methods. Since r-infestin 3-4 presented several
inhibitory activities, we decided to express the domains 3 and
4 separately to see which domain was responsible for each
activity. Surprisingly, the expressed infestin 3 domain did not
present inhibitory activity (data not shown) to the tested
serine proteases. In contrast, r-Infestin 4 presented an aﬃnity
to factor XIIa comparable to r-infestin 3-4. Puriﬁed r-infestin
4 was able to prolong coagulation time in APTT by ap-
proximately 3 times, inhibiting factor XIIa. The existence of
native factor XIIa inhibitor (infestin 4 or 3-4) in the midgut
was our next question.
The native factor XIIa inhibitory activity was detected as
expected and its amino terminal sequence determined. The
amino acid sequence contained residues localized in the loop
between domains 2 and 3. These data suggested that the native
factor XIIa inhibitor is a double Kazal-type domain protein
and its dissociation constant (Ki) for factor XIIa was similar to
that of r-infestin 3-4. The low quantity of native infestin 3-4
obtained did not allow us to perform other kinetic assays.ther Kazal type serine protease inhibitors. Inf 1-2, Infestin 1-2; Inf 3-4,
iin (Swiss-Prot # Q06684); Dip 3-4, Dipetalogastin; Dip 5-6, Dipeta-
ot # P09865); LDTI, leech derivated triptase inhibitor (Swiss-Prot #
. # indicates the N-terminal of r-infestin 3-4. The black box indicates
516 I.T.N. Campos et al. / FEBS Letters 577 (2004) 512–516Our data allowed us to conclude that infestins 3-4 and 1-2
act in cooperation, blocking the beginning and the end of the
blood coagulation cascade by inhibiting factor XIIa and
thrombin, respectively. The presence of infestin 1-2 and inf-
estin 3-4 demonstrated how the insect has evolved to overcome
the host’s hemostatic barrier. A possible explanation for inf-
estin 3-4 strong inhibition of factor XIIa may be that the most
active coagulation pathway is the intrinsic one, since T. infe-
stans is preferentially a vessel-feeder [8] and therefore the ex-
trinsic pathway may be poorly triggered. Factor XIIa is
important in the intrinsic pathway initialization [1] and is
strongly inhibited by infestin 3-4. If undesirable blood coag-
ulation activity occurs, the thrombin and factor Xa generated
may be inhibited by infestin 1-2 and infestin 3-4, respectively.
It is interesting to note that these inhibitory activities are
complementary and present in the same mRNA molecule.
These inhibitors are then separated, probably by a post tran-
scription processing.
Hematophagous animals are a rich source of anti-hemostatic
substances [3,24], but few inhibitors of the intrinsic pathway
have been described [27]. Among those described are a few
non-plasmatic factor XIIa inhibitors, most isolated from
plants [14–17], only ecotin was from E. coli [13] and none of
them were Kazal-type inhibitors. Infestin 3-4 is the ﬁrst potent
factor XIIa inhibitor to be isolated from a hematophagous
animal. The Kazal-type domain versatility in inhibiting serine
proteases deﬁnes them as an interesting tool for speciﬁcity
studies and new inhibitor developments. At this time, our
group is working on the infestin processing mechanisms.
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